| Literature DB >> 36231085 |
Ricardo Alva1, Georgina L Gardner1, Ping Liang1, Jeffrey A Stuart1.
Abstract
Most conventional incubators used in cell culture do not regulate O2 levels, making the headspace O2 concentration ~18%. In contrast, most human tissues are exposed to 2-6% O2 (physioxia) in vivo. Accumulating evidence has shown that such hyperoxic conditions in standard cell culture practices affect a variety of biological processes. In this review, we discuss how supraphysiological O2 levels affect reactive oxygen species (ROS) metabolism and redox homeostasis, gene expression, replicative lifespan, cellular respiration, and mitochondrial dynamics. Furthermore, we present evidence demonstrating how hyperoxic cell culture conditions fail to recapitulate the physiological and pathological behavior of tissues in vivo, including cases of how O2 alters the cellular response to drugs, hormones, and toxicants. We conclude that maintaining physioxia in cell culture is imperative in order to better replicate in vivo-like tissue physiology and pathology, and to avoid artifacts in research involving cell culture.Entities:
Keywords: ROS; drug response; gene expression; hyperoxia; metabolism; mitochondrial dynamics; oxidative stress; oxygen; physioxia; senescence
Mesh:
Substances:
Year: 2022 PMID: 36231085 PMCID: PMC9563760 DOI: 10.3390/cells11193123
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 7.666
Figure 1Pathways for intracellular oxygen/redox status sensing by HIF-1/2 and Nrf2. (A) Low O2 levels reduce the rate of HIF-1/2α hydroxylation, which leads to molecular recognition by the Von Hippel-Lindau tumor suppressor protein (pVHL) and subsequent proteasomal degradation. Stabilized HIF-1/2α binds HIF-β and translocates to the nucleus, where it binds the hypoxia response element (HRE) in DNA, inducing expression of glycolytic, proliferative, and pro-survival genes, among others. (B) High O2 levels promote increased reactive oxygen species (ROS) production. ROS-mediated oxidation of Keap1 releases Nrf2 preventing its proteasomal degradation. Nrf2 then translocates to the nucleus, heterodimerizes with small musculo-aponeurotic fibrosarcoma (sMaf), and binds to the antioxidant response element (ARE), inducing expression of genes involved in ROS and xenobiotic detoxification. Created with BioRender.com (accessed on 14 July 2022).
Effects of O2 tension (between 2–18% O2) on cellular metabolism, mitochondrial abundance, morphology, and network dynamics.
| Cell Types | Experimental Conditions | Methods | Outcomes | Reference |
|---|---|---|---|---|
|
| ||||
| Stem cells | hMSCs/18% or 3% O2 | Seahorse XF analysis, | ↑ OCR/ECAR ratio at 18% O2 | [ |
| hPSCs/18% or 5% O2 | Seahorse XF analysis, NMR spectroscopy, RNA-seq, RT-PCR | ↑ OCR/ECAR ratio at 18% O2 | [ | |
| MPCs from old mice/18% or 3% O2 | Seahorse XF analysis | ↓ OCR at 18% O2 | [ | |
| Primary differentiated cells | hCEnCs/18% or 2.5% O2 | Seahorse XF analysis | ↑ ECAR at 2.5% O2 | [ |
| Rat primary cortical neurons/18% or 5% O2 | ATP bioluminescent assay, LSC, lactate assay | ↑ glucose uptake at 5% O2 | [ | |
| HRPTEC/18–3% O2 | Resazurin assay | ↑ metabolic activity at 18% O2, compared to 15% and 12% O2 | [ | |
| Cancer/immortalized cells | U87MG/18–3% O2 | Resazurin assay | ↓ metabolic activity at 18% O2, compared to 8–3% O2 | |
| MCF-7/18–3% O2 | Resazurin assay | ↓ metabolic activity at 18% O2, compared to 8% O2 | ||
| MCF-7/18% or 5% O2 | Seahorse XF analysis | ↓ basal and maximal OCR | [ | |
| LNCaP/18% or 5% O2 | Seahorse XF analysis | ↓ basal OCR at 18% O2 | ||
| Huh-7/18% or 5% O2 | Seahorse XF analysis | ↓ basal and maximal OCR | ||
| SaOS2/18% or 5% O2 | Seahorse XF analysis | ↓ maximal OCR at 18% O2 | ||
|
| ||||
| Primary differentiated cells | rat primary neurons/18%, 5%, or 2% O2 | TEM and confocal microscopy; Image J | Globular-shaped mitochondria at 18% O2 (versus elongated at 2% and 5% O2) | [ |
| Cancer/immortalized cells | U87MG/18–3% O2 | Confocal microscopy; | Rounder mitochondria at 18% O2 | [ |
| HEK293/18–3% O2 | Confocal microscopy; | Rounder mitochondria at 18% O2 | ||
| MCF-7/18–3% O2 | Confocal microscopy; | Elongated mitochondria | ||
| LNCaP/18% or 5% O2 | Confocal microscopy; MiNA | ↓ mitochondrial footprint | [ | |
| Huh-7/18% or 5% O2 | Confocal microscopy; MiNA | ↑ mitochondrial footprint | ||
| SaOS2/18% or 5% O2 | Confocal microscopy; MiNA | ↑ mitochondrial footprint | ||
Abbreviations: ECAR, extracellular acidification rate; hCEnCs, human corneal endothelial cells; hMSCs, human mesenchymal stem cells; hPSC, human pluripotent stem cells; HRPTEC, human renal proximal tubule epithelial cells; LSC, liquid scintillation counting; MiNA, mitochondrial network analysis; NMR, nuclear magnetic resonance; OCR, oxygen consumption rate; TEM, transmission electron microscopy; XF, extracellular flux.
Differential cellular responses to drugs, hormones, and toxicants at atmospheric O2 versus physioxia.
| Molecule | Mechanism | Conditions | Outcomes | Reference |
|---|---|---|---|---|
|
| ||||
| resveratrol | ROS scavenger, multiple targets | PC-3 and C2C12 cells | Differential H2O2 production, proliferation, and mitochondrial network dynamics | [ |
| sulforaphane | ROS scavenger, multiple targets | bEnd.3 cells | Attenuated reoxygenation-induced ROS production at 18% O2 but not at 5% O2 | [ |
| quercetin | ROS scavenger, multiple targets | human neonatal foreskin fibroblasts | GSH depletion and loss of type I | [ |
| doxorubicin | DNA intercalating agent | HCT116, IMR90, U2OS, and MCF-7 cells | ↑ apoptosis at 18% O2 | [ |
| acetaminophen | COX inhibitor | mouse hepatocytes | ↑ hepatotoxicity at 18% O2 | [ |
| HepG2 cells | ↓ hepatotoxicity at 18% O2 | [ | ||
| cyclophosphamide | DNA cross-linking agent | HepG2 cells | ↓ hepatotoxicity at 18% O2 | [ |
| teriflunomide | pyrimidine synthesis | SW480 and SW620 cells | ↓ proapoptotic effect at 18% O2 | [ |
| oxaliplatin | DNA synthesis inhibitor | SW480 and SW620 cells | ↓ antiproliferative effect at 18% O2 | [ |
| paclitaxel | microtubule stabilizer | mouse mammary | ↑ cytotoxicity at 18% O2 | [ |
| alpelisib | PI3K inhibitor | mouse mammary | ↑ cytotoxicity at 18% O2 | [ |
| erlotinib | EGFR inhibitor | mouse mammary | ↑ cytotoxicity at 18% O2 | [ |
| vemurafenib | BRAFV600
| patient-derived | ↓ Ki-67-positive cells at 18% O2 | [ |
| trametinib | MEK1/2 | patient-derived | ↓ Ki-67-positive cells at 18% O2 | [ |
| camptothecin | topoisomerase inhibitor | U87MG cells | ↑ cytotoxicity at 18% O2 | [ |
| dimethyl fumarate | Nrf2 inducer | RAW 264.7 cells | ↑ expression of Nrf2 targets and antioxidant response | [ |
| glycolic acid | keratolytic, | Hs68 and HaCaT | Differential regulation of skin barrier | [ |
| gluconolactone | keratolytic, | Hs68 and HaCaT | Differential regulation of skin barrier | [ |
| salicylic acid | keratolytic, AMPKactivator | Hs68 and HaCaT | Differential regulation of skin barrier | [ |
|
| ||||
| 17β-estradiol | ER antagonist | C2C12 cells | Differential H2O2 production, metabolism, and mitochondrial network dynamics | [ |
|
| ||||
| LPS | TLR4 agonist | RAW 264.7 cells | ↑ production of inflammatory mediators | [ |
| rotenone | complex I | SH-SY5Y cells | ↓ cytotoxicity at 18% O2 | [ |
| acrolein | DNA and | differentiated | ↑ cytotoxicity at 18% O2 | [ |
| aflatoxin B | DNA adduct inducer | HepG2 cells | ↓ hepatotoxicity at 18% O2 | [ |
|
| ||||
| Prooxidant, | HepG2 cells | ↑ cytotoxicity at 18% O2 | [ | |
| CuO NPs | Prooxidant, genotoxic, | A549 cells | ↓ NP-induced oxidative stress at 18% O2 | [ |
Abbreviations: AMPK, AMP-dependent kinase; BRAFV600, B-raf (mutated); COX, cyclooxygenase; EGFR, epidermal growth factor receptor; ER, estrogen receptor; GSH, reduced glutathione; H/R, hypoxia/reoxygenation; LPS, lipopolysaccharide; MEK1/2, MAPK/ERK kinase 1/2; NPs, nanoparticles; PI3K, phosphatidylinositol 3-kinase; ROS, reactive oxygen species; mROS, mitochondrial ROS; RNS, reactive nitrogen species, TLR4, toll-like receptor 4.
Figure 2Cellular mechanisms differentially regulated at physioxia (2–6% O2) versus normoxia (18% O2). In physioxia (A), activation of HIF may drive the induction of genes that regulate glucose metabolism, survival, proliferation, differentiation, and other processes. In many cases, mitochondria have a more elongated morphology and form highly fused networks. In normoxia (B), increased ROS production by NADPH oxidases (NOX) and the electron transport chain (ETC) leads to oxidative stress, characterized by DNA and lipid oxidation, and promotes activation of a variety of pathways such as p53 and Nrf2, which, in turn, results in the induction of antioxidant genes and senescence. Further, in many instances, mitochondria show a more globular morphology and increased fission of mitochondrial networks. These cellular mechanisms result in nonphysiological phenotypes and differential responses to bioactive molecules. Created with BioRender.com (accessed on 26 September 2022).